Global Survey Reveals Gaps in Pet Parasite Awareness as Prevention Efforts Urged
A global survey released for World Parasite Awareness Day highlights gaps in pet parasite awareness as Boehringer Ingelheim urges stronger prevention efforts to... Read more.
Bayer’s Kerendia Gains EU Approval for Expanded Use in Heart Failure Treatment
Bayer receives European Commission approval to expand the use of Kerendia (finerenone) for adults with certain types of heart failure, broadening treatment options... Read more.
Department of Health – Abu Dhabi Shuts Down Five Facilities Over Serious Violations, Refers Case for Investigation
The Department of Health – Abu Dhabi has ordered the temporary closure of five healthcare facilities and suspended their staff, with cases referred to the Public... Read more.
Dubai Humanitarian dispatches critical medical aid for WHO to Lebanon through overland convoy
Under the directives of His Highness Sheikh Mohammed bin Rashid Al Maktoum, Vice President and Prime Minister of the UAE and Ruler of Dubai, Dubai Humanitarian (DXBH)... Read more.
Phase III Trials Show Tozorakimab Reduces COPD Exacerbations with Promising Safety Profile
Phase III trials indicate that tozorakimab effectively reduces COPD exacerbations and shows a favourable safety profile, offering potential for improved disease... Read more.
Lebanon Receives WHO and UNICEF Medical Aid Shipment to Strengthen Health System
Lebanon has received 3.5 tons of WHO-supported emergency medical supplies to sustain critical healthcare services amid rising system pressures. The Ministry of Public... Read more.
Novo Nordisk Secures FDA Approval for Once-Weekly Basal Insulin Awiqli®
Novo Nordisk’s once-weekly insulin Awiqli® has received FDA approval after phase 3 trials showed effective blood sugar control with a safety profile comparable... Read more.
SOZA Introduces On-Site Health Data Analytics and Stress Assessment Service for Organizations
SOZA has launched an on-site analytics service that enables organizations to monitor stress and wellbeing through advanced, clinic-free health assessments. SOZA... Read more.
Novartis agrees to acquire Excellergy, Inc.
Novartis has agreed to acquire Excellergy, adding a next-generation anti-IgE antibody therapy to strengthen its portfolio for treating IgE-driven allergic diseases.... Read more.
AbbVie Named Official Pharmaceutical Partner of Major League Baseball
AbbVie has partnered with Major League Baseball as its Official Pharmaceutical Partner, expanding its “Striking Out Cancer” initiative nationwide to raise awareness... Read more.
